NASDAQ:ORGO
Organogenesis Holdings Inc. Class A Stock News
$2.77
+0 (+0%)
At Close: May 21, 2024
Organogenesis (ORGO) Q1 Earnings Lag Estimates
09:35pm, Tuesday, 10'th May 2022 Zacks Investment Research
Organogenesis (ORGO) delivered earnings and revenue surprises of -80% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Organogenesis Holdings Inc. Reports First Quarter 2022 Financial Results
08:05pm, Tuesday, 10'th May 2022 GlobeNewswire Inc.
CANTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Organogenesis (ORGO) Q1 Earnings Lag Estimates
06:49pm, Tuesday, 10'th May 2022
Organogenesis (ORGO) delivered earnings and revenue surprises of -80% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Aziyo Biologics, Inc. (AZYO) Reports Q1 Loss, Tops Revenue Estimates
09:25pm, Monday, 09'th May 2022 Zacks Investment Research
Aziyo Biologics, Inc. (AZYO) delivered earnings and revenue surprises of 3.23% and 6.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring 2022 Conference
08:30pm, Tuesday, 05'th Apr 2022 GlobeNewswire Inc.
CANTON, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Organogenesis, a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the A
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
08:05pm, Tuesday, 05'th Apr 2022 GlobeNewswire Inc.
CANTON, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization o
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
04:05pm, Tuesday, 05'th Apr 2022
CANTON, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Strength Seen in Foghorn Therapeutics Inc. (FHTX): Can Its 5.3% Jump Turn into More Strength?
11:46am, Wednesday, 23'rd Mar 2022 Zacks Investment Research
Foghorn Therapeutics Inc. (FHTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the
Is This Healthcare Stock a Value Trap?
03:45pm, Thursday, 17'th Mar 2022 The Motley Fool
Don't be blinded by its attractive valuation.
Organogenesis Named One of 50 Highest Growth Companies in Massachusetts by the Boston Business Journal
01:00pm, Thursday, 17'th Mar 2022 GlobeNewswire Inc.
CANTON, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization o
Is This Healthcare Stock a Value Trap?
11:45am, Thursday, 17'th Mar 2022
Don't be blinded by its attractive valuation.
Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference
12:30pm, Tuesday, 08'th Mar 2022 GlobeNewswire Inc.
CANTON, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization o
Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference
07:30am, Tuesday, 08'th Mar 2022
CANTON, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Why Organogenesis Holdings Stock Blasted 21% Higher Today
10:48pm, Wednesday, 02'nd Mar 2022 The Motley Fool
The company delivered quite an upside surprise with its fourth-quarter earnings release.
Why Organogenesis Holdings Stock Blasted 21% Higher Today
05:48pm, Wednesday, 02'nd Mar 2022
The company delivered quite an upside surprise with its fourth-quarter earnings release.
